How to Use Checks and Balances in Your Medtech Start-Up: Interview with Michael Tozzi, President and CEO of TAS Medical

On this episode of Medsider Radio, I had the chance to sit down
with Michael Tozzi, President and CEO of TAS Medical. Mike and
his team are aiming to eliminate surgical mesh by converting
hernia procedures to minimally invasive repairs.


Mike has over 20 years of commercial medical device experience
and specializes in investor relations, sales & marketing
readiness, and improving the execution of early-stage medical
device companies.. 


Previous to TAS Medical, Mike served as Chief Commercial Officer
at Carevoyance, where he and his team created groundbreaking
analytics tools designed to help medical device companies better
understand their markets and execute their commercial goals.


Prior to this, Mike helped to build Cardiovascular Systems, Inc.
(or CSI) from the ground floor, taking the company from early
stage to over $1.3 billion in market capitalization in just seven
years. At CSI, Mike held various executive roles in sales and
marketing. 


Joining me on this episode is special guest host, Norbert Juist,
who runs Sales Performance Resources, which specializes in
recruiting for medtech marketing and sales positions. Prior to
this, he was a sales rep at Cordis Endovascular, a spine
consultant at Synthes, and a sales rep at Ethicon. 


Interview Highlights with Mike Tozzi


The origin story of TAS Medical and how Mike got involved.

The strategies that TAS Medical followed to go from initial
product concept to eventual commercialization.

The regulatory and clinical paths that Mike and his team
considered.

How much the insurance coverage and reimbursement landscape
factored into Mike’s early decision-making process.

Mike’s approach to raising capital for CSI and TAS
Medical. 

Common mistakes that early-stage medtech companies make and
how to avoid them.

Mike’s favorite book, the business leader he most admires,
and the advice he’d give to his 30-year old self.



See more...